|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
Cambridge, Massachusetts, US
|
|
TCR² Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer. TCR²’s proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). In preclinical studies, TRuC-T cells have demonstrated superior anti-tumor activity compared to chimeric antigen receptor T cells (CAR-T cells), while exhibiting lower levels of cytokine release.
|
TCR² Therapeutics Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first} | [email protected] |
75%
|
The widely used TCR² Therapeutics Inc. email format is {first} (e.g. [email protected]) with 75% adoption across the company.
To contact TCR² Therapeutics Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.